In 2024, the U.S. Drug Enforcement Administration (DEA) indicated that they intend to reclassify cannabis to be a Plan III drug. This rescheduling will understand that cannabis has genuine healthcare purposes and can help open up the door to study on other potential treatment takes advantage of. One prospective exception https://thcdisposables.co.uk/